24 of the top 25 pharmaceutical companies use our ecosystem comprising validated digital health technologies, digital biomarkers, eCOAs, research partners, and educational tools.
Customers have saved up to 1 year of research time and $3 million working with HumanFirst. Accelerate drug development, reduce costs, and improve confidence of submissions with evidence-based precision measures.
Prioritize patient-centered research by understanding and measuring what matters to patients. Increase diversity in clinical trials by leveraging AI-powered digital biomarkers.
Industry-standard frameworks backed by the most comprehensive library of evidence, spanning over 15,000 measures and 3,000 technologies
Up to $3M in savings due to reduction in avoidable protocol amendments across the clinical development lifecycle for a single asset
Deploy patients in trials up to 12 months faster than traditional methods with precision measurement recommendations backed by evidence
Our team prioritizes open-access publications and has been featured in top peer-reviewed journals.
